About
▼
Overview
Leadership
Our Team
Board of Directors
Investors
Science
▼
Overview
Highly Cytotoxic T Cells
KLRG1
Publications
Pipeline
▼
Overview
ABC008
IBM
T-LGLL
Additional Indications
ABC015
News
Careers
Contact
About
Abcuro
Breakthrough Therapies for Autoimmune Diseases & Cancer
About
Overview
Leadership
Our Team
Board of Directors
Investors
Science
Overview
Highly Cytotoxic T Cells
KLRG1
Publications
Pipeline
Overview
ABC008
IBM
T-LGLL
Additional Indications
ABC015
News
Careers
Contact
Weems Gary
August 6, 2022
Garry Weems
VP, Clinical Science
x
Garry Weems
VP, Clinical Science
